With the industry already beginning to wind up for RSNA, respondents to last week’s reader survey indicated that they expect that PACS and RIS (35.5 percent) and Molecular Imaging (19.4 percent) will be the most buzz-worthy technology at the show. Placing third was CT at just under 10 percent.